Resultaten visas 1 - 10 / 14123
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Production, purification and immunogenicity of recombinant Ebola virus proteins - A comparison of Freund's adjuvant and adjuvant system 03

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jviromet.2016.12.014
Melen, Krister; Kakkola, Laura; He, Felix; Airenne, Kari; Vapalahti, Olli; Karlberg, Helen; Mirazirn...
Journal of virological methods2017Publicationer information ikon

Melanom - kan vi påverka överlevnaden hos melanompatienter med adjuvant behandling?

Öppen tillgång
Hernberg, Mikaela
Finska läkaresällskapets handlingar2019Publicationer information ikon

Adjuvant imatinib for GIST:duration likely matters

DOI
10.1016/j.annonc.2021.01.073
Eriksson, M.; Joensuu, H.
Annals of oncology2021Publicationer information ikon

Cardiotoxicity of adjuvant breast cancer radiotherapy

Skyttä Tanja
Suomen Yliopistopaino Oy2016Publicationer information ikon

Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study

Referentgranskad
Öppen tillgång
DOI
10.21873/anticanres.12142
Aula, Hanna; Skytta, Tanja; Tuohinen, Suvi; Luukkaala, Tiina; Hamalainen, Mari; Virtanen, Vesa; Raat...
Anticancer research2017Publicationer information ikon

Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients

Referentgranskad
DOI
10.1016/j.ejca.2022.02.003
van Mackelenbergh, Marion T.; Seither, Fenja; Möbus, Volker; O'Shaughnessy, Joyce; Martin, Miguel; J...
European journal of cancer2022Publicationer information ikon

Duration of adjuvant trastuzumab: shorter beats longer

DOI
10.1016/S0140-6736(13)61448-8
Joensuu, Heikki
The Lancet2013Publicationer information ikon

Adjuvant treatments for triple-negative breast cancers

Referentgranskad
DOI
10.1093/annonc/mds194
Joensuu, Heikki; Gligorov, J.
Annals of oncology2012Publicationer information ikon

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib

Referentgranskad
Öppen tillgång
DOI
10.3390/cancers15153879
Joensuu, Heikki
Cancers2023Publicationer information ikon

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

Referentgranskad
Öppen tillgång
DOI
10.1007/s00432-023-04622-4
Iivanainen, Sanna; Ravichandra, Ravi; Jekunen, Antti; Arokoski, Reetta; Mentu, Santeri; Lang, Laura;...
Journal of cancer research and clinical oncology2023

Production, purification and immunogenicity of recombinant Ebola virus proteins - A comparison of Freund's adjuvant and adjuvant system 03

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jviromet.2016.12.014
2017

Melanom - kan vi påverka överlevnaden hos melanompatienter med adjuvant behandling?

Öppen tillgång
2019

Adjuvant imatinib for GIST:duration likely matters

DOI
10.1016/j.annonc.2021.01.073
2021

Cardiotoxicity of adjuvant breast cancer radiotherapy

2016

Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level - A Prospective Observational Study

Referentgranskad
Öppen tillgång
DOI
10.21873/anticanres.12142
2017

Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients

Referentgranskad
DOI
10.1016/j.ejca.2022.02.003
2022

Duration of adjuvant trastuzumab: shorter beats longer

DOI
10.1016/S0140-6736(13)61448-8
2013

Adjuvant treatments for triple-negative breast cancers

Referentgranskad
DOI
10.1093/annonc/mds194
2012

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib

Referentgranskad
Öppen tillgång
DOI
10.3390/cancers15153879
2023

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

Referentgranskad
Öppen tillgång
DOI
10.1007/s00432-023-04622-4
2023